Effects of omeprazole or cola beverage on the pharmacokinetics of oral DA-8159, a new erectogenic, in rats.

The changes in pharmacokinetics of DA-8159 by omeprazole with respect to inhibition of CYP3A1/2 in rats were evaluated. After oral administration of DA-8159 at dose of 30 mg/kg to rats pretreated with oral omeprazole at 30 mg/kg for 1 week, the total area under the plasma concentration-time curve from time zero to time infinity (AUC) of DA-8159 was significantly greater (37.5% increase) than that in control rats. This could be due to inhibition of metabolism of DA-8159 by inhibition of CYP3A1/2 by omeprazole. The AUC(DA-8164 (a metabolite of DA-8159))/AUC(DA-8159) ratio was also smaller (32.4% decrease) with omeprazole. After oral administration of DA-8159 at a dose of 30 mg/kg to rats without or with cola beverage, the pharmacokinetic parameters of DA-8159 and DA-8164 were not significantly different between two groups of rats. This suggested that cola beverage did not have any considerable effects on CYP3A1/2 in rats.

[1]  So H. Kim,et al.  Interspecies pharmacokinetic scaling of DA‐8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics , 2005, Biopharmaceutics & drug disposition.

[2]  Yu C. Kim,et al.  Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous DA‐8159, a new erectogenic, in rats , 2005, Biopharmaceutics & drug disposition.

[3]  M. Gibaldi,et al.  Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjects , 1977, Journal of Pharmacokinetics and Biopharmaceutics.

[4]  M. Danhof,et al.  Influence of single- and multiple-dose omeprazole treatment on nifedipine pharmacokinetics and effects in healthy subjects , 2004, European Journal of Clinical Pharmacology.

[5]  S. Garg,et al.  Influence of an acidic beverage (Coca-Cola) on the pharmacokinetics of phenytoin in healthy rabbits. , 2003, Methods and findings in experimental and clinical pharmacology.

[6]  G. Ahn,et al.  Efficacy of DA-8159, a new PDE5 inhibitor, for inducing penile erection in rabbits with acute spinal cord injury , 2003, International Journal of Impotence Research.

[7]  Yu C. Kim,et al.  Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects. , 2003, Journal of pharmaceutical sciences.

[8]  W. Kim,et al.  DA-8159, a new PDE5 Iihibitor, induces penile erection in conscious and acute spinal cord injured rabbits. , 2003, European urology.

[9]  M. Son,et al.  Mechanism of erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159 , 2002, Archives of pharmacal research.

[10]  So H. Kim,et al.  Determination of a new phosphodiesterase V inhibitor, DA-8159, in plasma and urine by high-performance liquid chromatography. , 2002, Journal of pharmaceutical and biomedical analysis.

[11]  A. Nicoll,et al.  Effect of omeprazole‐induced achlorhydria on trefoil peptide expression in the rat stomach , 2001, Journal of gastroenterology and hepatology.

[12]  H. S. Lee,et al.  Pharmacokinetics, stability, and blood partition of DA-8159, a new phosphodiesterase V inhibitor. , 2000, Research communications in molecular pathology and pharmacology.

[13]  S. Sriwiriyajan,et al.  Effect of omeprazole on the pharmacokinetics of itraconazole , 1998, European Journal of Clinical Pharmacology.

[14]  M. Klausner,et al.  Effect of a Cola Beverage on the Bioavailability of Itraconazole in the Presence of H2 Blockers , 1997, Journal of clinical pharmacology.

[15]  J. Houston,et al.  Selectivity of omeprazole inhibition towards rat liver cytochromes P450. , 1997, Xenobiotica; the fate of foreign compounds in biological systems.

[16]  S. Binkley,et al.  Interaction of human liver cytochromes P450 in vitro with LY307640, a gastric proton pump inhibitor. , 1996, Pharmacogenetics.

[17]  D. Waxman,et al.  Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. , 1986, The Journal of biological chemistry.

[18]  W. L. Chiou.  New calculation method for mean apparent drug volume of distribution and application to rational dosage regimens. , 1979, Journal of pharmaceutical sciences.